Which is a treatment option for BPH?

Alpha-blockers are a primary treatment option for benign prostatic hyperplasia (BPH) because they work by relaxing the muscles of the bladder neck and prostate, leading to improved urine flow and decreased symptoms related to urinary obstruction. These medications, such as tamsulosin and doxazosin, help alleviate the difficulty in urination, frequency, and urgency commonly associated with BPH.

In contrast, while aspirin, statins, and fish oil play significant roles in various other health conditions, they do not target the specific mechanism of action needed to relieve the urinary symptoms caused by BPH. Aspirin is primarily used for its anti-inflammatory and antiplatelet effects, statins are aimed at lowering lipid levels to reduce cardiovascular risk, and fish oil is often related to cardiovascular health and anti-inflammatory properties. None of these options directly address the physiological issues stemming from BPH, making alpha-blockers the most appropriate choice for treating this specific condition.